{"name":"Otsuka Novel Products GmbH","slug":"otsuka-novel-products-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxNUF9DLTVqN1JWVHVwaWQ3MTI1U2FoVG92YzVWb0xESlJYcTQ4QTc5YXFNb2hoRlBPdGxhUllteXdJX3ZOVzBLYVQ4QUlkTXpXM1RnWkd1b2VySmJjeWJCTDdqb2EtaG1RMVN6bmdaUU5KTTV6LVlzUlBlYmhsUzFqcHA3cnFfdElVUlVORjBEa1FXUFZNRHBaQUtCLUZiZm1zd2xsOHdTWGllRloxVUd0ZFluU1hxQVl5b05ib0sycjdSNzZwZ0M2dDliWXVsNTU5VVJ5MHZhU2NmMXNhcmkwcUt4MFo3TGhhaXhFNERrclNia1JwclNrcl80ckl6b0VSbmZhWV8xVUcyc2tNRzZsdmRQRE9JNXRSVHJGbVFZaw?oc=5","date":"2025-03-06","type":"pipeline","source":"businesswire.com","summary":"Neurology Market Research Overview 2025, Profiles of Major Players - F. Hoffmann-La Roche, Novartis, UCB, and Otsuka - ResearchAndMarkets.com - businesswire.com","headline":"Neurology Market Research Overview 2025, Profiles of Major Players - F. Hoffmann-La Roche, Novartis, UCB, and Otsuka - R","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5ubDNPLVVOa0MteTNiT0otSGtuZXhfV1hFNW55X2xueXBsVnpicTA5RkNFdDBsdTJXZjZYTlZUZm11dUhYQ05NS3FIeWVnRnpDM3ZIVUVKNnF3VVA2RVBjYlNYVVJvNXM?oc=5","date":"2024-03-11","type":"pipeline","source":"MedPage Today","summary":"Triplet Regimen Shortens Effective TB Treatment - MedPage Today","headline":"Triplet Regimen Shortens Effective TB Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOa3VPUXQ2bl9LZVJFZjh4YkliNzViS3U5WG1qNzNLOXktQ3VUTE5VcTMwbkp6R290eEF2YUdXaHU5eVFWbDBDYTREZ3FqZ3Nyd1hQWVhENl9wczVwS3psa0VLQ3pRWk5HZ3RPT0E5aVFxNzF4R2Z0dGtqTnhfel9uNDdzTi1GcnNrODY4ZXUtZGpkY2VNQTBmTXM3RWloX2t0U2pRYVRqSExOYjF5ZWJhYngtUnc?oc=5","date":"2024-03-11","type":"pipeline","source":"Daily Maverick","summary":"New TB drug shows promise, but experimental vaccine disappoints - Daily Maverick","headline":"New TB drug shows promise, but experimental vaccine disappoints","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBWQ3BVdTdFNGVtOXJmb21tVFhBekFvNlJxSUQ2UXJGYm13bnlhMDBHQ3Atc3hVU0h1MlBRTXZZRTczektsaUtweDVXYktYVWg4VG9yLXNXOC0taE1NS2NvcG1VdkZGdEVtdG1tUmwxUVRRUQ?oc=5","date":"2017-12-17","type":"pipeline","source":"otsuka.co.jp","summary":"DELTYBA Product story | Otsuka Pharmaceutical Co., Ltd. - otsuka.co.jp","headline":"DELTYBA Product story | Otsuka Pharmaceutical Co., Ltd.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxQOExYcFJZTmlZR21jUXFLODN3ek5FLU9DZjNsR2NhVXo1Mk50TWowWUVDN0FXdER5Zm1TZW9LSHhUU1MzajBGelpqV2xzVUMta3hGZFZ3TmdzX1FKRnQ4LU5hVndCSVFXNS1hcHZQb0tTYzMxUWJ0T3hWREhxVDhjcE9Cb0lNaURKdENHTjhNTE5wWUFlSE9Ccm4zRWgwR1V2X3M3Mmk1cXliV0k0NDVQdGJ4d2I2SkNoZWdkMF9UN2ZxTHNGb2pDR09XYjh4QUFxNXJoWE1aemJwTkotajVpN1J4cXNkRGJ1eWROY2Z4dWxqbDhuR1ZxY29JR2hNclc3OXFxYndmcC1ESUdDQmwxZGtMSGltX21IU2c3XzMyeHM0WVNzV3p3Q0hITQ?oc=5","date":"2017-08-24","type":"deal","source":"prnewswire.com","summary":"Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba™) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries - prnewswire.com","headline":"Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba™) for Multidrug-Resistant Tuberculosis (","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1FVGpyWHkxZ1V4NU5DQkhNN3RlY3lXV1dSaFFWOFdwWnQ4SFR5SzBMRXNSSi02clB0WGZ4TkRob3MtXzFXM2RGclNTMVIzMkVDTTRFUzcwRFBxY1N5c1V5Y05ndTh4V1VmNmszYTJNRE1Kc0RwWV9jNg?oc=5","date":"2010-04-26","type":"pipeline","source":"otsuka.co.jp","summary":"Core of Global Basic Research Drug Discovery Research Building \"10th Research Center\" Completed on April 26 - otsuka.co.jp","headline":"Core of Global Basic Research Drug Discovery Research Building \"10th Research Center\" Completed on April 26","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}